University Invests in Ultima UG100 Genome Sequencer
Trusted by teams at
Description
The University of Minnesota made a major genomics instrumentation investment by purchasing the Ultima UG100 for its Genomics Center, enabling large-scale, cost-effective genome sequencing. The investment positions UMN as a leader in genomics technology with subsidized internal usage rates.
Contract Details
Vendor
ULTIMA
Agency
University of Minnesota Board of Regents, MN
Contract Type
EQUIPMENT
Document Date
February 12, 2026
Contract Term
three-year investment (began 2024)
Renewal Date
2027-12-31
Renewal Info
Three-year investment; continuation contingent on grant and infrastructure program funding.
More from ULTIMA
More from University of Minnesota Board of Regents
Board of Regents Agenda Packet April 2026
Board of Regents Agenda Packet April 2026
Board of Regents Agenda Packet February 2026
University of Minnesota Board of Regents Meeting Agenda February 2026
University of Minnesota Board of Regents Meeting Agenda February 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.